Your browser doesn't support javascript.
loading
The 2018 adult heart allocation policy change benefits low-volume transplant centers.
Kim, Samuel T; Tran, Zachary; Xia, Yu; Hadaya, Joseph; Williamson, Catherine G; Gandjian, Matthew; Choi, Chun Woo; Benharash, Peyman.
Affiliation
  • Kim ST; Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Tran Z; Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Xia Y; Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Hadaya J; Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Williamson CG; Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Gandjian M; Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Choi CW; Division of Cardiovascular Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Benharash P; Cardiovascular Outcomes Research Laboratories (CORELAB), Division of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Clin Transplant ; 35(8): e14389, 2021 08.
Article in En | MEDLINE | ID: mdl-34154036
ABSTRACT

INTRODUCTION:

The effect of the 2018 adult heart allocation policy change at an institution-level remains unclear. The present study assessed the impact of the policy change by transplant center volume.

METHODS:

The United Network for Organ Sharing database was queried for all adults undergoing isolated heart transplantation from November 2016 to September 2020. Era 1 was defined as the period before the policy change and Era 2 afterwards. Hospitals were divided into low-(LVC) medium-(MVC) and high-volume (HVC) tertiles based on annual transplant center volume. Competing-risks regressions were used to determine changes in waitlist death/deterioration, while post-transplant mortality was assessed using multivariable Cox proportional-hazards models.

RESULTS:

A total of 3531 (47.0%) patients underwent heart transplantation in Era 1 and 3988 (53.0%) in Era 2. At LVC, Era 2 patients were less likely to experience death/deterioration on the waitlist (subhazard ratio .74, 95% CI .63-.88), while MVC and HVC patients experienced similar waitlist death/deterioration across eras. After adjustment, transplantation in Era 2 was associated with worse 1-year mortality at MVC (hazard ratio, HR, 1.42 95% CI 1.02-1.96) and HVC (HR 1.42, 95% CI 1.02-1.98) but not at LVC.

CONCLUSION:

Early analysis shows that LVC may be benefitting under the new allocation scheme.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Transplantation / Transplants Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Transplantation / Transplants Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2021 Type: Article Affiliation country: United States